Literature DB >> 10873170

Metabolic and respiratory effects of theophylline in the preterm infant.

V P Carnielli1, G Verlato, F Benini, K Rossi, M Cavedagni, M Filippone, E Baraldi, F Zacchello.   

Abstract

BACKGROUND: Methylxanthines are often administered to preterm infants for the treatment of apnoea. AIMS: To study the effects of theophylline on energy metabolism, physical activity, and lung mechanics in preterm infants.
METHODS: Indirect calorimetry was performed for six hours before and after administration of a bolus of theophylline (5 mg/kg) in 18 preterm infants while physical activity was recorded with a video camera. Lung mechanics measurements were performed at baseline and 12 and 24 hours after theophylline treatment.
RESULTS: Theophylline increased mean (SEM) energy expenditure by 15 (5) kJ/kg/day and augmented carbohydrate utilisation from 6.8 to 8.0 g/kg/day, but fat oxidation was unchanged. After theophylline treatment, preterm infants had faster respiration, lower transcutaneous CO2, and improved static respiratory compliance without increased physical activity.
CONCLUSIONS: A bolus of 5 mg/kg theophylline increased energy expenditure independently of physical activity, increased carbohydrate utilisation, and improved respiratory compliance. The increased energy expenditure could be detrimental to the growth of the preterm infant.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873170      PMCID: PMC1721103          DOI: 10.1136/fn.83.1.f39

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  31 in total

1.  Oxygen consumption and neonatal sleep states.

Authors:  J K Stothers; R M Warner
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

2.  Effect of aminophylline on respiratory center activity and metabolic rate in premature infants with idiopathic apnea.

Authors:  T Gerhardt; J McCarthy; E Bancalari
Journal:  Pediatrics       Date:  1979-04       Impact factor: 7.124

3.  Bronchopulmonary effects of caffeine in the anesthetized dog.

Authors:  M Oskoui; D M Aviado; S Bellet
Journal:  Respiration       Date:  1970       Impact factor: 3.580

4.  Aminophylline therapy for idiopathic apnea in premature infants: effects on lung function.

Authors:  T Gerhardt; J McCarthy; E Bancalari
Journal:  Pediatrics       Date:  1978-11       Impact factor: 7.124

5.  Oxygen consumption in apneic premature infants after low-dose theophylline.

Authors:  R L Milsap; A N Krauss; P A Auld
Journal:  Clin Pharmacol Ther       Date:  1980-10       Impact factor: 6.875

6.  Effects of theophylline on behavioral state development in the newborn rabbit.

Authors:  V H Denenberg; L P Zeidner; E B Thoman; P Kramer; J C Rowe; A F Philipps; J R Raye
Journal:  J Pharmacol Exp Ther       Date:  1982-06       Impact factor: 4.030

7.  Metabolic responses to plasma concentrations of theophylline.

Authors:  W F Cathcart-Rake; J L Kyner; D L Azarnoff
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

8.  Effect of aminophylline on cerebral haemodynamics and oxidative metabolism in premature infants.

Authors:  H U Bucher; M Wolf; M Keel; K von Siebenthal; G Duc
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

9.  Alterations in state in apneic pre-term infants receiving theophylline.

Authors:  J Dietrich; A N Krauss; M Reidenberg; D E Drayer; P A Auld
Journal:  Clin Pharmacol Ther       Date:  1978-10       Impact factor: 6.875

10.  Pharmacologic considerations in the therapy of neonatal apnea.

Authors:  J V Aranda; D Grondin; B I Sasyniuk
Journal:  Pediatr Clin North Am       Date:  1981-02       Impact factor: 3.278

View more
  5 in total

Review 1.  Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.

Authors:  Katherine Schoen; Tian Yu; Chris Stockmann; Michael G Spigarelli; Catherine M T Sherwin
Journal:  Paediatr Drugs       Date:  2014-04       Impact factor: 3.022

Review 2.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 3.  Cardiorespiratory events in preterm infants: etiology and monitoring technologies.

Authors:  J M Di Fiore; C F Poets; E Gauda; R J Martin; P MacFarlane
Journal:  J Perinatol       Date:  2015-11-19       Impact factor: 2.521

Review 4.  Mechanistic actions of oxygen and methylxanthines on respiratory neural control and for the treatment of neonatal apnea.

Authors:  Lisa Mitchell; Peter M MacFarlane
Journal:  Respir Physiol Neurobiol       Date:  2019-10-15       Impact factor: 1.931

Review 5.  Apnea of prematurity: from cause to treatment.

Authors:  Jing Zhao; Fernando Gonzalez; Dezhi Mu
Journal:  Eur J Pediatr       Date:  2011-02-08       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.